Rebecca C. Auer, MD, MSc, FRCSC, FACS (she/her/hers)

Director of Cancer Research
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada

Dr. Rebecca Auer is the Scientific Director for the Cancer Therapeutics Program at the Ottawa Hospital Research Institute. She is a Surgical Oncologist specializing in Colorectal Cancer Surgery and Retroperitoneal Sarcomas at The Ottawa Hospital, a Professor in the Department of Surgery and the Department of Biochemistry, Microbiology and Immunology at the University of Ottawa and the Director of Cancer Research at The Ottawa Hospital. Dr. Auer holds a Tier 1 Clinical Research Chair in Perioperative Cancer Therapeutics and leads a translational research program focuses on understanding the promotion of metastatic disease in the perioperative period, following surgical stress.

Presentation(s):

• Sustainable Systems for Surgical Oncology; Balancing the Health of the Population and the Planet

  Friday, March 22, 2024
  10:30am – 11:00am ET

• 24: Phase 1b Randomized Controlled Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy (PERIOP-04)

  Friday, March 22, 2024
  11:12am – 11:22am ET

• Designing the Next Trials in CRLM - Interactive Discussion

  Friday, March 22, 2024
  4:34pm – 4:45pm ET

• P56: Characterizing postoperative antigen-specific T and B cell dysfunction to COVID-19 in cancer surgery patients.

  Saturday, March 23, 2024
  11:23am – 11:29am ET